Product
FTC/TDF
Aliases
PrEP
5 clinical trials
12 indications
Indication
Preexposure Prophylaxis for HIVIndication
HIV-IIndication
HIV-1Indication
ProphylaxisIndication
HIV InfectionsIndication
Bone DemineralizationIndication
HypoestrogenismIndication
Subclinical Kidney InjuryIndication
Bone MicroarchitectureIndication
HIVIndication
PreventionIndication
PregnancyClinical trial
A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of Oral Islatravir Once-Monthly as Preexposure Prophylaxis in Cisgender Men and Transgender Women Who Have Sex With Men, and Are at High Risk for HIV-1 InfectionStatus: Completed, Estimated PCD: 2023-08-04
Clinical trial
A Phase 3, Randomized, Active-Controlled, Double-blind Clinical Study to Evaluate the Efficacy and Safety of Oral Islatravir Once-Monthly as Preexposure Prophylaxis in Cisgender Women at High Risk for HIV-1 InfectionStatus: Active (not recruiting), Estimated PCD: 2023-07-18
Clinical trial
A Phase 2a Crossover Trial Evaluating the Safety of and Adherence to a Vaginal Matrix Ring Containing Dapivirine and Oral Emtricitabine/Tenofovir Disoproxil Fumarate in an Adolescent and Young Adult Female PopulationStatus: Completed, Estimated PCD: 2021-09-09
Clinical trial
Impact of Concurrent Initiation of DMPA Contraception and Tenofovir PrEP on Bone Loss in Young WomenStatus: Completed, Estimated PCD: 2022-02-21
Clinical trial
Optimizing PrEP Regimens for Pregnant Women in Sub-Saharan Africa (O-PrEP Study) - Stage 1Status: Not yet recruiting, Estimated PCD: 2025-02-01